Prosecution Insights
Prosecution Insights
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §102 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DROUIN, STEVE HOANG | 1 | 100.0% | +0.0% |
| MARTIN, KEVIN STEPHEN | 1 | 75.7% | +24.4% |
| ANDERSON, REBECCA L | 1 | 73.3% | +23.8% |
| COPPINS, JANET L | 1 | 72.9% | +25.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18572861 | ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | DROUIN, STEVE HOANG | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18281127 | PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME | ANDERSON, REBECCA L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18289476 | NOVEL TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS | MARTIN, KEVIN STEPHEN | 5d overdue |
| 18281127 | PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME | ANDERSON, REBECCA L | — |
| 17714879 | ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | COPPINS, JANET L | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| 1624 | 1 |
| 1626 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18572861 | ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | DROUIN, STEVE HOANG | 1627 | §102Other | Non-Final OA | — | Pending | Dec 21, 2023 |
| 18289476 | NOVEL TRYPTAMINES AND METHODS OF TREATING MOOD DISORDERS | MARTIN, KEVIN STEPHEN | 1624 | §103 | Non-Final OA | 5d overdue | Pending | Nov 03, 2023 |
| 18281127 | PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME | ANDERSON, REBECCA L | 1626 | §102§103 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 17714879 | ARYLCYCLOHEXYLAMINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS | COPPINS, JANET L | 1628 | §112DP | Final Rejection | — | Pending | Apr 06, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial